featured
Recommended and Prevalent Use of GLP-1 Receptor Agonists and SGLT2 Inhibitors in a National Population-Based Sample
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Annals of Internal Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Recommended and Prevalent Use of Glucagon-like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter-2 Inhibitors in a National Population-Based Sample
Ann. Intern. Med 2023 Feb 28;[EPub Ahead of Print], S Tang, H Shao, MK Ali, P ZhangFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.